01 1Alivus Life Sciences
01 1SUCRALFATE USP (PROCESS-II)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-10-18
Pay. Date : 2022-09-28
DMF Number : 37502
Submission : 2022-09-30
Status : Active
Type : II
20
Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SUCRALFATE USP (PROCESS-II), with a corresponding US DMF Number 37502.
Remarkably, this DMF maintains an Active status since its submission on September 30, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 18, 2022, and payment made on September 28, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
